Export 1817 results:
Sort by: [ Author  (Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S [T] U V W X Y Z   [Show ALL]
TA, G., K. NA, N. MM, and H. H, "Subclinical renal involvement in essential cryoglobulinemic vasculitis and classic polyarteritis nodosa", Joint Bone Spine, vol. 79, issue 3, pp. 274-80, 2012. AbstractWebsite

Renal vasculitis is usually associated with anti-neutrophil cytoplasmic antibodies (ANCAs). However, non-ANCA patients constitute a rarely studied variant of renal vasculitis. The aim of the present study was to demonstrate the features of renal involvement in patients with primary systemic non-ANCA associated vasculitis (NAAV) and compare essential cryoglobulinemic vasculitis (ECV) with classic polyarteritis nodosa (PAN).
The study included 30 patients with primary systemic non-ANCA associated vasculitis (NAAV). Fifteen with ECV and another 15 patients with classic PAN. The patients were recruited from the Rheumatology and Internal medicine departments and outpatient clinics of Cairo University Hospitals. The patients had no or mild renal involvement at entry and the ANCA was negative as tested by immunoflourescence and ELISA. Renal biopsy was performed for all the patients and histopathologically studied.
Renal biopsy abnormalities were seen in six females. One patient with PAN showed renal vasculitis and membranoproliferative glomerulonephritis (MPGN) and was HBV and ANA positive. The patient had negative HCV and cryoglobulins. Five patients with ECV-associated HCV had findings; one had chronic interstitial nephritis and was HBV positive. The other four were HBV negative with MPGN in two, focal proliferative and crescentic GN in one patient each.
Increased understanding of the manifestations of systemic vasculitis is likely to provide the basis for the use of more selective immunomodulatory therapies in the future. It is our hope that this study will raise awareness of the non ANCA-associated vasculitic renal involvement

TA, G., E. - F. HS, N. MM, and H. H, "Insulin resistance and metabolic syndrome in primary gout: relation to punched-out erosions", Int J Rheum Dis, vol. 15, issue 6, pp. 521-5, 2012. Abstract


To verify the relation of gout to insulin resistance (IR) and metabolic syndrome (MetS) and find any association of metatarsophalangeal (MTP) joint erosions to the features of MetS and IR.


Forty-six primary gout male patients with a mean age of 41.96 ± 5.77 years were grouped according to the presence of MetS. Twenty-seven age and sex matched healthy volunteers served as controls. Insulin sensitivity was estimated using the homeostatic model assessment index (HOMA-B) for beta cell function and HOMA-IR for peripheral tissue IR.


Gout patients had significantly higher HOMA-IR and HOMA-B compared to controls. Those with MetS (n = 27) had significantly higher serum uric acid (SUA) than those without (n = 19; 11.51 ± 3.72 mg/dL vs. 9.15 ± 2.34 mg/dL; P = 0.012). Gout patients with MTP erosions had notable higher insulin levels and more IR as shown by the higher levels of HOMA-IR and HOMA-B compared to those without. HOMA-IR and HOMA-B significantly correlated with the presence of erosions. Moreover, the presence of erosions significantly correlated with SUA (r = 0.64, P < 0.0001).


The level of SUA is closely related to IR in patients with and without MetS. There is an association of the severity of gout and presence of MTP erosions to IR. Metabolic syndrome forms an important marker for those who develop more punched-out erosions.

TA, M., and M. MM, "The effect of glycemic control on visual and anatomic outcomes in response to therapy for diabetic macular edema.", Eur J Ophthalmol, vol. 23, issue 1, pp. 94-100, 2013. Abstract

Purpose. To evaluate the effect of glycemic control on response to therapy of diabetic clinically significant macular edema (CSME). Methods. Patients with CSME had their glycosylated hemoglobin (HbA1c) measured at baseline and 6 months. Central foveal thickness (CFT) and best-corrected visual acuity (BCVA) in logMAR were measured at baseline, 3 months, and 6 months. Therapy included laser and intravitreal bevacizumab. HbA1c was graded as G1 <7%, G23 7%–7.9%, G3 8%–8.9%, G4 >9%. Results. Fifty-two eyes were included with mean logMAR BCVA and CFT as follows: baseline 0.75 and 423±106 µm; 3 months 0.47 and 293±69 µm; and 6 months 0.48 and 324±76 µm. Mean HbA1c was 8.13% and 7.43% at baseline and 6 months, respectively. There was no statistically significant difference between baseline and 6 months HbA1c groups and logMAR BCVAs and CFTs at baseline, 3 months, and 6 months. However, there were positive correlations between baseline HbA1c levels and each of baseline logMAR BCVA (p=0.024), baseline CFT (p<0.001), and 6-month logMAR BCVA (p=0.007). Improved HbA1c by 6 months did not show any correlation with logMAR BCVA and CFT at 6 months. Conclusions. Lower HbA1c appeared to be correlated with better visual acuity and lower CFT values at baseline, and also correlated with significantly better vision and nonsignificantly thinner CFT with therapy at 6 months.

TA,  I., H. HM, and E. H. AA, ". Antioxidant potential and phenolic acid content of", Nat.Prod.Research , vol. 24, issue 16, pp. 1537-45, 2010.
Tabaa, M. M. E., H. M. Aboalazm, M. Shaalan, and N. F. Khedr, "Silymarin constrains diacetyl-prompted oxidative stress and neuroinflammation in rats: involvements of Dyn/GDNF and MAPK signaling pathway.", Inflammopharmacology, 2022. Abstract

Neuroinflammation, a major component of many CNS disorders, has been suggested to be associated with diacetyl (DA) exposure. DA is commonly used as a food flavoring additive and condiment. Lately, silymarin (Sily) has shown protective and therapeutic effects on neuronal inflammation. The study aimed to explore the role of Sily in protecting and/or treating DA-induced neuroinflammation. Neuroinflammation was induced in rats by administering DA (25 mg/kg) orally. Results revealed that Sily (50 mg/kg) obviously maintained cognitive and behavioral functions, alleviated brain antioxidant status, and inhibited microglial activation. Sily enhanced IL-10, GDNF and Dyn levels, reduced IFN-γ, TNFα, and IL-1β levels, and down-regulated the MAPK pathway. Immunohistochemical investigation of EGFR and GFAP declared that Sily could conserve neurons from inflammatory damage. However, with continuing DA exposure during Sily treatment, oxidative stress and neuroinflammation were less mitigated. These findings point to a novel mechanism involving the Dyn/GDNF and MAPK pathway through which Sily might prevent and treat DA-induced neuroinflammation.

Tabak, S. A., S. E. Khalifa, and Y. E. - F. Esawy, "HER-2 Immunohistochemical Expression in Bone Sarcomas; A New Hope for Osteosarcoma patients", Open access Macedonian Journal of Medical Sciences, vol. 318, 2018.
Tabashy, R., and S. EL-Rahman, "Role of the Multidetector CT Angiography in the assessment of Renal Vascular Anomalies", The Medical Journal of Cairo University, vol. 82, issue 1, pp. 375-385, 2014.
Tabashy, R., A. Shabana, A. Aly, and A. Gaballah, "Role of Color Doppler Ultrasound in the Assessment of Complications of Epididymoorchitis", The Egyptian Journal of Radiology and Nuclear Medicine, vol. 41, issue 2, pp. 221-226, 2010.
Tabashy, R., H. Moharram., I. Hamed., and S. Zakarya, Role of Endosonography in Diagnosis and Staging of Gastric Carcinoma, , Cairo, Cairo University, 1999.
Tabashy, R., A. Hamed, A. Darwish, and M. El-Azab, "Modified percutaneous radiologic gastrostomy technique without endoscopic or nasogastric access", ECR,, 2014, 2015.
Tabashy, R., A. Hamed, A. Darwish, and M. El-Azab, "Modified percutaneous radiologic gastrostomy technique without endoscopic or nasogastric access", European Conference of Radiology (ECR), Vienna, Austria, 12 March, 2015.
Tabashy, R., H. Moharram, I. Hamed, and H. El-Zawahry, The Role of Radiofrequency Ablation in Treatment of Hepatic Malignancies, , Cairo, Cairo University, 2004.
Tabashy, R., A. Hamed, and S. El-Sebai, "Interventional management of postoperative ureteric complications after pelvic surgery", European Conference of Radiology (ECR), Vienna, Austria, 12 March, 2015.
Tabashy, R., A. Gaballah, A. Shabana, and S. Eid, "Radifrequency Ablation of Colorectal Liver Metastases", The Egyptian Journal of Radiology & Nuclear Medicine, vol. 39, issue 2, pp. 783-794, 2008.
Taber, D. F., R. A. Hassan, and P. W. DeMatteo, "Simplified Preparation of Dimethyldioxirane (DMDO)", Organic Syntheses, vol. 90, pp. 350-357, 2013. dmdo.pdf
Tabll, A. A., S. B. Khalil, R. M. EI-Shenawy, G. Esmat, A. Helmy, A. F. Attallah, and M. K. Ei-Awadyl, "Establishment of hybrid cell lines producing monoclonal antibodies to a synthetic peptide from the E1 region of the hepatitis C virus", JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY, vol. 29, no. 1, pp. 91-104, 2008. Abstract
Tada, H., H. Yamasaki, Y. Sekiguchi, M. Igarashi, K. Kuroki, T. Machino, K. Yoshida, K. Aonuma, F. R. Heinzel, H. Forstner, et al., "Poster Session 4", Europace, vol. 13, no. suppl 3: Eur Heart Rhythm Assoc, pp. NP–NP, 2011. Abstract
Tadesse, L. F., F. Safir, C. - S. Ho, X. Hasbach, B. P. Khuri-Yakub, S. S. Jeffrey, A. A. E. Saleh, and J. Dionne, "Toward rapid infectious disease diagnosis with advances in surface-enhanced Raman spectroscopy.", The Journal of chemical physics, vol. 152, issue 24, pp. 240902, 2020. Abstract

In a pandemic era, rapid infectious disease diagnosis is essential. Surface-enhanced Raman spectroscopy (SERS) promises sensitive and specific diagnosis including rapid point-of-care detection and drug susceptibility testing. SERS utilizes inelastic light scattering arising from the interaction of incident photons with molecular vibrations, enhanced by orders of magnitude with resonant metallic or dielectric nanostructures. While SERS provides a spectral fingerprint of the sample, clinical translation is lagged due to challenges in consistency of spectral enhancement, complexity in spectral interpretation, insufficient specificity and sensitivity, and inefficient workflow from patient sample collection to spectral acquisition. Here, we highlight the recent, complementary advances that address these shortcomings, including (1) design of label-free SERS substrates and data processing algorithms that improve spectral signal and interpretability, essential for broad pathogen screening assays; (2) development of new capture and affinity agents, such as aptamers and polymers, critical for determining the presence or absence of particular pathogens; and (3) microfluidic and bioprinting platforms for efficient clinical sample processing. We also describe the development of low-cost, point-of-care, optical SERS hardware. Our paper focuses on SERS for viral and bacterial detection, in hopes of accelerating infectious disease diagnosis, monitoring, and vaccine development. With advances in SERS substrates, machine learning, and microfluidics and bioprinting, the specificity, sensitivity, and speed of SERS can be readily translated from laboratory bench to patient bedside, accelerating point-of-care diagnosis, personalized medicine, and precision health.

Tadesse, L. F., C. - S. Ho, D. - H. Chen, H. Arami, N. Banaei, S. S. Gambhir, S. S. Jeffrey, A. A. E. Saleh, and J. Dionne, "Plasmonic and Electrostatic Interactions Enable Uniformly Enhanced Liquid Bacterial Surface-Enhanced Raman Scattering (SERS).", Nano letters, vol. 20, issue 10, pp. 7655-7661, 2020. Abstract

Surface-enhanced Raman spectroscopy (SERS) is a promising cellular identification and drug susceptibility testing platform, provided it can be performed in a controlled liquid environment that maintains cell viability. We investigate bacterial liquid-SERS, studying plasmonic and electrostatic interactions between gold nanorods and bacteria that enable uniformly enhanced SERS. We synthesize five nanorod sizes with longitudinal plasmon resonances ranging from 670 to 860 nm and characterize SERS signatures of Gram-negative and and Gram-positive and bacteria in water. Varying the concentration of bacteria and nanorods, we achieve large-area SERS enhancement that is independent of nanorod resonance and bacteria type; however, bacteria with higher surface charge density exhibit significantly higher SERS signal. Using cryo-electron microscopy and zeta potential measurements, we show that the higher signal results from attraction between positively charged nanorods and negatively charged bacteria. Our robust liquid-SERS measurements provide a foundation for bacterial identification and drug testing in biological fluids.

Tadros, M. I., and R. H. Fahmy, "Controlled-release triple anti-inflammatory therapy based on novel gastroretentive sponges: Characterization and magnetic resonance imaging in healthy volunteers.", International Journal of Pharmaceutics, vol. 472, issue 1-2, pp. 27-39, 2014.
Tadros, S. J., D. H. Mohamed, M. M. S.Ahmed, and Y. H. A. Hussein, "Effect of Adipose-derived stem cells versus clomiphen on treatment of experimental polycystic ovary in rats: Histological and Immunohistochemical study", egyptian journal of histology, vol. 41 , issue 4, pp. 373-385, 2018.
Tadros, S. A., Y. M. Attia, N. W. Maurice, S. A. Fahim, F. M. Abdelwahed, S. Ibrahim, and O. A. Badary, "Thymoquinone Suppresses Angiogenesis in DEN-Induced Hepatocellular Carcinoma by Targeting miR-1-3p.", International journal of molecular sciences, vol. 23, issue 24, 2022. Abstract

Hepatocellular carcinoma (HCC) is characterized by its high vascularity and metastasis. Thymoquinone (TQ), the main bio-active constituent of , has shown anticancer and hepatoprotective effects. TQ's anticancer effect is mediated through miRNA regulation. miR-1-3p plays a significant role in various cancers but its role in HCC invasiveness remains poorly understood. Bio-informatics analysis predicted that the 3'-UTR of TIMP3 is a target for miR-1-3p; Rats were equally divided into four groups: Group 1, the negative control; Group 2 received TQ; Group 3 received DEN; and Group 4 received DEN after pretreatment with TQ. The expression of TIMP3, MMP2, MMP9, and VEGF in rats' liver was determined immunohistochemically. RT-qPCR was used to measure the miR-1-3p level in rats' liver, and TIMP3, MMP2, MMP9, and VEGF in the HepG2 cells after being transfected with miR-1-3p mimic or inhibitor; In rats pretreated with TQ, a decreased expression of MMP2, MMP9 and VEGF, and increased expression levels of TIMP3 and miR-1-3p were detected. Treating the HepG2 cells with miR-1-3p mimic led to the upregulation of TIMP3 and downregulation of MMP2, MMP9, and VEGF, and showed a significant delay in wound healing; These results suggested that the anti-angiogenic effect of TQ in HCC may be mediated through the regulation of miR-1-3p.